(BTI) British American Tobacco - Ratings and Ratios
Cigarettes, Vapour, Nicotine, Snus, Snuff
BTI EPS (Earnings per Share)
BTI Revenue
Description: BTI British American Tobacco
British American Tobacco p.l.c. (NYSE:BTI) is a multinational tobacco company operating globally, offering a diverse range of nicotine products including vapour, heated, and modern oral nicotine products, as well as combustible cigarettes and traditional oral products. The companys portfolio includes well-known brands such as Vuse, glo, Velo, Grizzly, Kodiak, Dunhill, Kent, Lucky Strike, Pall Mall, Rothmans, Newport, Natural American Spirit, and Camel.
The companys global presence spans across the Americas, Europe, the Asia-Pacific, the Middle East, Africa, and the United States, with products distributed to retail outlets. With a history dating back to 1902, British American Tobacco p.l.c. is headquartered in London, the United Kingdom. As a leading player in the tobacco industry, the company is navigating the evolving landscape of nicotine products and regulatory environments.
From a financial perspective, British American Tobacco p.l.c. has a market capitalization of approximately $111 billion USD. The companys dividend yield is an important metric, currently standing at around 7-8%, making it an attractive option for income-seeking investors. Additionally, the companys return on equity (ROE) has been negative in recent times, standing at -46.44%, indicating potential challenges in generating profits. However, the forward price-to-earnings (P/E) ratio is around 10.43, suggesting that the company may be undervalued relative to its future earnings potential.
Key performance indicators (KPIs) to monitor for British American Tobacco p.l.c. include revenue growth, EBITDA margins, and the proportion of revenue generated from next-generation products (NGPs) such as vapour and heated tobacco products. The companys ability to adapt to changing regulatory environments and consumer preferences will be crucial in driving future growth. Other important metrics include the companys debt-to-equity ratio and its ability to maintain a stable dividend payout.
BTI Stock Overview
| Market Cap in USD | 127,446m |
| Sub-Industry | Tobacco |
| IPO / Inception | 1980-04-14 |
BTI Stock Ratings
| Growth Rating | 86.4% |
| Fundamental | 83.3% |
| Dividend Rating | 77.5% |
| Return 12m vs S&P 500 | 53.2% |
| Analyst Rating | 3.40 of 5 |
BTI Dividends
| Dividend Yield 12m | 9.20% |
| Yield on Cost 5y | 19.20% |
| Annual Growth 5y | 1.82% |
| Payout Consistency | 88.9% |
| Payout Ratio | 2.0% |
BTI Growth Ratios
| Growth Correlation 3m | 96.1% |
| Growth Correlation 12m | 93% |
| Growth Correlation 5y | 62% |
| CAGR 5y | 20.39% |
| CAGR/Max DD 5y | 0.68 |
| Sharpe Ratio 12m | 3.18 |
| Alpha | 71.27 |
| Beta | 0.035 |
| Volatility | 20.49% |
| Current Volume | 4824.2k |
| Average Volume 20d | 4675.6k |
| Stop Loss | 57.2 (-3.1%) |
| Signal | 2.41 |
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income (-10.03b TTM) > 0 and > 6% of Revenue (6% = 3.11b TTM) |
| FCFTA 0.15 (>2.0%) and ΔFCFTA 4.47pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -4.10% (prev -4.31%; Δ 0.22pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.15 (>3.0%) and CFO 16.29b > Net Income -10.03b (YES >=105%, WARN >=100%) |
| Net Debt (31.65b) to EBITDA (14.60b) ratio: 2.17 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.87 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (2.20b) change vs 12m ago -1.55% (target <= -2.0% for YES) |
| Gross Margin 82.49% (prev 73.90%; Δ 8.60pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 45.23% (prev 29.04%; Δ 16.19pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 3.57 (EBITDA TTM 14.60b / Interest Expense TTM 3.54b) >= 6 (WARN >= 3) |
Altman Z'' 1.45
| (A) -0.02 = (Total Current Assets 13.88b - Total Current Liabilities 16.00b) / Total Assets 110.23b |
| (B) 0.16 = Retained Earnings (Balance) 17.94b / Total Assets 110.23b |
| (C) 0.11 = EBIT TTM 12.62b / Avg Total Assets 114.47b |
| (D) 0.29 = Book Value of Equity 18.52b / Total Liabilities 63.35b |
| Total Rating: 1.45 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 83.31
| 1. Piotroski 5.50pt = 0.50 |
| 2. FCF Yield 13.50% = 5.0 |
| 3. FCF Margin 31.88% = 7.50 |
| 4. Debt/Equity 0.68 = 2.27 |
| 5. Debt/Ebitda 2.19 = -0.36 |
| 6. ROIC - WACC 16.78% = 12.50 |
| 7. RoE -19.60% = -2.50 |
| 8. Rev. Trend 79.93% = 4.00 |
| 9. Rev. CAGR 23.50% = 2.50 |
| 10. EPS Trend -8.42% = -0.21 |
| 11. EPS CAGR 21.16% = 2.12 |
What is the price of BTI shares?
Over the past week, the price has changed by +3.22%, over one month by +14.42%, over three months by +35.42% and over the past year by +75.86%.
Is British American Tobacco a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of BTI is around 72.02 USD . This means that BTI is currently undervalued and has a potential upside of +22.05% (Margin of Safety).
Is BTI a buy, sell or hold?
- Strong Buy: 1
- Buy: 2
- Hold: 1
- Sell: 0
- Strong Sell: 1
What are the forecasts/targets for the BTI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 54.4 | -7.8% |
| Analysts Target Price | 46.4 | -21.4% |
| ValueRay Target Price | 77.8 | 31.9% |
Last update: 2025-08-12 10:00
BTI Fundamental Data Overview
CCE Cash And Equivalents = 4.40b GBP (last quarter)
P/E Trailing = 30.7
P/E Forward = 12.3762
P/S = 4.9791
P/B = 2.022
P/EG = 0.4636
Beta = 0.149
Revenue TTM = 51.78b GBP
EBIT TTM = 12.62b GBP
EBITDA TTM = 14.60b GBP
Long Term Debt = 31.90b GBP (from longTermDebt, last quarter)
Short Term Debt = unknown (0.0)
Debt = 31.90b GBP (Calculated: Short Term 0.0 + Long Term 31.90b)
Net Debt = 31.65b GBP (from netDebt column, last fiscal year)
Enterprise Value = 122.27b GBP (94.77b + Debt 31.90b - CCE 4.40b)
Interest Coverage Ratio = 3.57 (Ebit TTM 12.62b / Interest Expense TTM 3.54b)
FCF Yield = 13.50% (FCF TTM 16.51b / Enterprise Value 122.27b)
FCF Margin = 31.88% (FCF TTM 16.51b / Revenue TTM 51.78b)
Net Margin = -19.38% (Net Income TTM -10.03b / Revenue TTM 51.78b)
Gross Margin = 82.49% ((Revenue TTM 51.78b - Cost of Revenue TTM 9.06b) / Revenue TTM)
Tobins Q-Ratio = 6.60 (Enterprise Value 122.27b / Book Value Of Equity 18.52b)
Interest Expense / Debt = 2.21% (Interest Expense 704.0m / Debt 31.90b)
Taxrate = 10.09% (from yearly Income Tax Expense: 357.0m / 3.54b)
NOPAT = 11.35b (EBIT 12.62b * (1 - 10.09%))
Current Ratio = 0.87 (Total Current Assets 13.88b / Total Current Liabilities 16.00b)
Debt / Equity = 0.68 (Debt 31.90b / last Quarter total Stockholder Equity 46.87b)
Debt / EBITDA = 2.19 (Net Debt 31.65b / EBITDA 14.60b)
Debt / FCF = 1.93 (Debt 31.90b / FCF TTM 16.51b)
Total Stockholder Equity = 51.18b (last 4 quarters mean)
RoA = -9.10% (Net Income -10.03b, Total Assets 110.23b )
RoE = -19.60% (Net Income TTM -10.03b / Total Stockholder Equity 51.18b)
RoCE = 15.19% (Ebit 12.62b / (Equity 51.18b + L.T.Debt 31.90b))
RoIC = 21.87% (NOPAT 11.35b / Invested Capital 51.88b)
WACC = 5.09% (E(94.77b)/V(126.67b) * Re(6.14%)) + (D(31.90b)/V(126.67b) * Rd(2.21%) * (1-Tc(0.10)))
Shares Correlation 5-Years: -100.0 | Cagr: -1.13%
Discount Rate = 6.14% (= CAPM, Blume Beta Adj.) -> floored to rf + ERP 8.05%
[DCF Debug] Terminal Value 79.76% ; FCFE base≈14.89b ; Y1≈16.56b ; Y5≈21.71b
Fair Price DCF = 172.5 (DCF Value 376.99b / Shares Outstanding 2.18b; 5y FCF grow 12.89% → 3.0% )
Revenue Correlation: 79.93 | Revenue CAGR: 23.50%
Rev Growth-of-Growth: 15.74
EPS Correlation: -8.42 | EPS CAGR: 21.16%
EPS Growth-of-Growth: 253.7
Additional Sources for BTI Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle